Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today that it will showcase its innovative Purion™...

NextEra Energy Partners, LP (NYSE: NEP) has posted its fourth-quarter and full-year 2022 financial results in a news release available on the partnership's website by accessing the following link:...

NextEra Energy, Inc. (NYSE: NEE) has posted its fourth-quarter and full-year 2022 financial results in a news release available on the company's website by accessing the following link:...

Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune...

Data demonstrates that STC-15, an oral METTL3 inhibitor, exhibits efficacy as a single agent and in combination with venetoclax using patient-derived tumor models STC-15 Phase 1 study in solid...